Literature DB >> 1356567

Haemodynamic effects of dicentrine, a novel alpha 1-adrenoceptor antagonist: comparison with prazosin in spontaneously hypertensive and normotensive Wistar-Kyoto rats.

S M Yu1, S Y Hsu, F N Ko, C C Chen, Y L Huang, T F Huang, C M Teng.   

Abstract

1. The haemodynamic effects of dicentrine, an aporphine derivative isolated from the plant Lindera megaphylla, were investigated and compared with prazosin in rats. 2. In anaesthetized normotensive Wistar-Kyoto (WKY) rats, i.v. administration of dicentrine (0.1, 0.5, 1.0 mg kg-1) and prazosin (0.01, 0.05, 0.1 mg kg-1) induced a dose-related reduction of mean arterial pressure (MAP) which reached a maximal effect 5-10 min after injection and persisted for 2 h. 3. In anaesthetized WKY rats, a higher dose of dicentrine (1.0 mg kg-1, i.v.) did not cause any significant changes in heart rate (HR), cardiac output (CO) and stroke volume (SV) but markedly increased tail blood flow. In contrast, a higher dose of prazosin (0.1 mg kg-1, i.v.) produced a decrease in HR which paralleled the time course of the hypotensive response. 4. The hypotensive activity of dicentrine was completely abolished by alpha-adrenoceptor blockade. Both dicentrine and prazosin significantly attenuated pressor responses to noradrenaline but failed, even at maximal hypotensive doses, to impair the pressor effects of angiotensin II or vasopressin. These observations suggest that dicentrine appears to exert its hypotensive action through alpha 1-adrenoceptor blockade. 5. In conscious normotensive and spontaneously hypertensive (SH) rats, dicentrine (0.5-2.0 mg kg-1, i.v.) and prazosin (0.05-0.2 mg kg-1, i.v.) also evoked dose-related decreases in MAP which were of greater magnitude in SH rats. Oral administration of dicentrine (5 and 8 mg kg-1) to conscious SH rats caused a hypotensive effect which persisted for over 15 h.6. These results suggest that dicentrine may have therapeutic potential as an oral antihypertensive drug via alpha-adrenoceptor blockade.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1356567      PMCID: PMC1907686          DOI: 10.1111/j.1476-5381.1992.tb14415.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  19 in total

Review 1.  A survey of the pharmacological properties of metoprolol in animals and man.

Authors:  B Ablad; K O Borg; E Carlsson; L EK; G Johnson; T Malmfors; C G Regårdh
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1975

2.  The effect of sympatholytic drugs on the cardiovascular responses to epinephrine and norepinephrine in man.

Authors:  E D FREIS; J C MacKAY; W F OLIVER
Journal:  Circulation       Date:  1951-02       Impact factor: 29.690

3.  The pharmacology of antihypertensive drugs with special reference to vasodilators, alpha-adrenergic blocking agents and prazosin.

Authors:  D Cambridge; M J Davey; R Massingham
Journal:  Med J Aust       Date:  1977-08-20       Impact factor: 7.738

4.  Prazosin and presynaptic alpha-receptors in the cardioaccelerator nerve of the dog.

Authors:  J W Constantine; R A Weeks; W K McShane
Journal:  Eur J Pharmacol       Date:  1978-07-01       Impact factor: 4.432

Review 5.  Drug therapy. Prazosin.

Authors:  J Koch-Weser; R M Graham; W A Pettinger
Journal:  N Engl J Med       Date:  1979-02-01       Impact factor: 91.245

6.  Alpha blocking action of the antihypertensive agent, prazosin.

Authors:  R M Graham; H F Oates; L M Stoker; G S Stokes
Journal:  J Pharmacol Exp Ther       Date:  1977-06       Impact factor: 4.030

7.  A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs.

Authors:  R Massingham; M L Hayden
Journal:  Eur J Pharmacol       Date:  1975-01       Impact factor: 4.432

8.  Influence of prazosin on cardiac reflex function.

Authors:  D W Hardey; M F Lokhandwala
Journal:  Eur J Pharmacol       Date:  1979-08-01       Impact factor: 4.432

Review 9.  Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure.

Authors:  W F Stanaszek; D Kellerman; R N Brogden; J A Romankiewicz
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

10.  Regional blood flow measurement with pulsed Doppler flowmeter in conscious rat.

Authors:  J R Haywood; R A Shaffer; C Fastenow; G D Fink; M J Brody
Journal:  Am J Physiol       Date:  1981-08
View more
  6 in total

1.  β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways.

Authors:  Giovanni Fajardo; Mingming Zhao; Gerald Berry; Lee-Jun Wong; Daria Mochly-Rosen; Daniel Bernstein
Journal:  J Mol Cell Cardiol       Date:  2011-07-02       Impact factor: 5.000

2.  Vasorelaxant effect of isoliquiritigenin, a novel soluble guanylate cyclase activator, in rat aorta.

Authors:  S M Yu; S C Kuo
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

3.  Effects of dicentrine on haemodynamic, plasma lipid, lipoprotein level and vascular reactivity in hyperlipidaemic rats.

Authors:  S M Yu; Y F Kang; C C Chen; C M Teng
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

4.  Plant derived aporphinic alkaloid S-(+)-dicentrine induces antinociceptive effect in both acute and chronic inflammatory pain models: evidence for a role of TRPA1 channels.

Authors:  Deise Prehs Montrucchio; Marina Machado Córdova; Adair Roberto Soares Santos
Journal:  PLoS One       Date:  2013-07-04       Impact factor: 3.240

Review 5.  A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji).

Authors:  Yueping Jiang; Min Liu; Haitao Liu; Shao Liu
Journal:  Phytochem Rev       Date:  2020-04-24       Impact factor: 5.374

Review 6.  Chemical constituents and bioactivity of Formosan lauraceous plants.

Authors:  Hsun-Shuo Chang; Ih-Sheng Chen
Journal:  J Food Drug Anal       Date:  2016-01-05       Impact factor: 6.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.